Geigert. (2013). The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics (2.). Springer New York.
Cita Chicago (17th ed.)Geigert. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics. 2. Springer New York, 2013.
Cita MLA (8th ed.)Geigert. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics. 2. Springer New York, 2013.
Atenció: Aquestes cites poden no estar 100% correctes.